Key Takeaways
- GxP is an umbrella covering GMP, GLP, GCP, and GDP — your applicable standard depends on your lab type and activities.
- ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available) is the FDA's non-negotiable data integrity framework.
- CAPA documentation failures are the #1 cited observation in FDA 483s for small labs.
- AI-assisted documentation can be GxP compliant when paired with human-in-the-loop review and a validated workflow.
- An audit trail must be tamper-evident, time-stamped, and user-attributable — not just a log file.
What Does "GxP" Actually Mean?
GxP is a collective term for a series of Good Practice (GP) regulations enforced by the FDA, EMA, and other regulatory bodies. The "x" is a placeholder for the applicable discipline:
- ·GMP (Good Manufacturing Practice): Governs pharmaceutical and medical device manufacturing. Regulations: 21 CFR Part 210/211 (drugs), 21 CFR Part 820 (devices), EU GMP.
- ·GLP (Good Laboratory Practice): Applies to non-clinical safety studies submitted to regulatory authorities. Regulations: 21 CFR Part 58, OECD GLP principles.
- ·GCP (Good Clinical Practice): Governs clinical trial conduct and documentation. Regulations: ICH E6(R2/R3), 21 CFR Part 312.
- ·GDP (Good Distribution Practice): Covers distribution chain integrity. EU GDP Guidelines, USP <1079>.
For most small QC labs supporting pharma or diagnostics, GMP is the primary applicable standard. CLIA-certified labs additionally follow 42 CFR Part 493. ISO 17025-accredited labs must also align with ILAC G8 data integrity guidance.
ALCOA+: The Foundation of GxP Data Integrity
FDA's 2018 Data Integrity Guidance and the 2022 Computer Software Assurance (CSA) guidance both reinforce ALCOA+ as the cornerstone of compliant documentation. Every record your lab creates — on paper or electronically — must satisfy all nine ALCOA+ attributes:
Common ALCOA+ Failure: Contemporaneous Recording
FDA 483 observations frequently cite lab analysts recording results on scratch paper and transcribing them later. Any gap between the activity and the record creates a data integrity vulnerability — even if the data itself is accurate.
Building an FDA-Defensible Audit Trail
Under 21 CFR Part 11, electronic records must include secure, computer-generated, time-stamped audit trails that independently record operator entries and actions. A compliant audit trail must be:
- Automatically generated — not manually created or reconstructed
- Time-stamped with UTC or a system clock that cannot be adjusted by users
- User-attributed — each entry linked to a unique user ID, not a shared login
- Change-captured — records original entry, any modification, who changed it, and why
- Tamper-evident — any alteration to the audit trail itself must be detectable
- Retained for the same period as the record it supports (often 2+ years post-study or batch release)
Paper-based labs are not exempt. Paper audit trails require controlled numbering, ink-only corrections (single strikethrough, date, and initials), and secure storage. FDA investigators will request raw data alongside final records and compare them for consistency.
CAPA Documentation: The #1 Inspection Finding
FDA Warning Letters and 483 Observations consistently cite CAPA deficiencies as the most frequent GMP violation for small labs and pharma facilities. Common failures include:
- ✗Root cause analysis limited to 'operator error' without systemic investigation
- ✗Corrective actions that address symptoms, not root causes
- ✗No documented effectiveness check after CAPA implementation
- ✗CAPA timelines not defined or consistently overdue
- ✗Deviation trends not analyzed across CAPA records
A compliant CAPA record must include: deviation description with batch/lot/equipment reference, immediate containment action, root cause investigation methodology (e.g., fishbone, 5-Why, fault tree), documented root cause conclusion, corrective and preventive actions with owners and due dates, and a defined effectiveness check with pass/fail criteria.
Where AI-Assisted Documentation Fits in GxP
FDA's 2022 Computer Software Assurance (CSA) guidance explicitly enables a risk-based approach to validating AI and software tools used in regulated environments. AI-assisted documentation is GxP-compliant when:
- The AI tool is validated or the workflow includes human verification at each critical step (CSA testing rigor matched to risk level)
- Every AI-generated output undergoes documented human-in-the-loop review before entering the quality system
- Prompts and AI model versions are version-controlled and documented in an audit trail
- The system does not make autonomous GxP decisions — AI drafts, humans approve
- Data submitted to AI systems are governed by appropriate data processing agreements
LabComplyx is designed around these principles. Every AI-drafted document is flagged as a draft until a qualified reviewer signs off. The system maintains an immutable log of who drafted, who reviewed, and who approved — satisfying 21 CFR Part 11 requirements.
Frequently Asked Questions
What does GxP compliance mean for small labs?
GxP compliance means adhering to Good Practice (GP) guidelines relevant to your lab type — GMP for manufacturing, GLP for non-clinical studies, or GCP for clinical trials. For small labs, this translates to maintaining complete, accurate, contemporaneous, and attributable records (ALCOA+) for every testing and documentation activity.
Which FDA regulations apply to small QC labs?
Small QC labs supporting pharmaceutical manufacturing must comply with 21 CFR Part 211 (finished pharmaceuticals), 21 CFR Part 820 (medical devices), and 21 CFR Part 11 (electronic records). CLIA-certified labs follow 42 CFR Part 493. All must maintain ALCOA+ data integrity standards.
What is the most common GxP documentation failure in FDA inspections?
The most common failure is inadequate CAPA documentation — either missing root cause analysis, incomplete corrective actions, or lack of effectiveness verification. Second most common is data integrity violations: backdating records, incomplete audit trails, or missing contemporaneous documentation.
How do I build an inspection-ready audit trail?
An inspection-ready audit trail must be: Attributable (who did it), Legible (readable), Contemporaneous (recorded at time of action), Original (first-captured record), and Accurate (reflecting what actually happened). Electronic systems must include time-stamped entries, user identification, and change history that cannot be altered without detection.
Ready to Strengthen Your GxP Documentation?
Get a free documentation maturity assessment. We'll identify your highest-risk gaps against FDA, ICH, and ISO standards — and give you a prioritized action plan.